Cambridge, MA, United States of America

Guo He

USPTO Granted Patents = 8 


 

Average Co-Inventor Count = 11.2

ph-index = 3

Forward Citations = 39(Granted Patents)


Location History:

  • Lexington, MA (US) (2014)
  • Cambridge, MA (US) (2016 - 2023)

Company Filing History:


Years Active: 2014-2023

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Guo He: Innovator in Chirally-Enriched RNA Agents

Introduction

Guo He is a prominent inventor based in Cambridge, MA (US), known for his significant contributions to the field of biotechnology. With a total of 8 patents, he has made remarkable advancements in the development of chirally-modified RNA agents and selective estrogen receptor degraders.

Latest Patents

One of Guo He's latest patents is focused on chirally-enriched double-stranded RNA agents. This invention relates to a chirally-modified dsRNA agent capable of inhibiting the expression of a target gene. The sense and antisense strands of this chirally-modified dsRNA agent can independently or in combination comprise one or more site-specific, chirally-modified internucleotide linkages. Another notable patent involves benzothiophene derivatives and compositions thereof as selective estrogen receptor degraders. This invention pertains to compounds of a specific formula that have potential therapeutic applications.

Career Highlights

Throughout his career, Guo He has worked with leading companies in the pharmaceutical industry, including Novartis AG and Astex Therapeutics Limited. His work in these organizations has allowed him to contribute to groundbreaking research and development in drug discovery and biotechnology.

Collaborations

Guo He has collaborated with several notable professionals in his field, including Heather Elizabeth Burks and Michael A Dechantsreiter. These collaborations have further enhanced his research and innovation capabilities.

Conclusion

Guo He is a distinguished inventor whose work in chirally-modified RNA agents and selective estrogen receptor degraders has made a significant impact in biotechnology. His contributions continue to advance the field and hold promise for future therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…